Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders??? Equity (Deficiency)

v3.22.2
Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and Shareholders’ Equity (Deficiency) - USD ($)
$ in Thousands
Seed
Redeemable convertible preferred Shares
Series A
Redeemable convertible preferred Shares
Series A-1
Redeemable convertible preferred Shares
Series B
Redeemable convertible preferred Shares
Series B-1
Redeemable convertible preferred Shares
Series B-2
Redeemable convertible preferred Shares
Total
Ordinary shares
Additional paid-in-capital
Accumulated deficit
Total
Balance at Dec. 31, 2018 $ 650 [1] $ 9,394 [1] $ 2,500 [1]       $ 12,544 [1] [1],[2] $ 407 [1] $ (20,322) [1] $ (19,915)
Balance (in Shares) at Dec. 31, 2018 [1] 5,540,254 7,780,937 5,460,043         8,909,813      
Issuance of redeemable convertible preferred shares $ 30,982 30,982  
Issuance of redeemable convertible preferred shares (in Shares)       10,468,517              
Conversion of convertible loan $ 10,447 10,447  
Conversion of convertible loan (in Shares)         4,144,887            
Share-based compensation 411   411
Warrants to service providers 58   58
Exercise of options [2]   [2]
Exercise of options (in Shares)               136,461      
Net loss   (25,607) (25,607)
Balance at Dec. 31, 2019 $ 650 [1] $ 9,394 [1] $ 2,500 [1] $ 30,982 [1] $ 10,447 [1] [1] 53,973 [1] [1],[2] 876 [1] (45,929) [1] (45,053)
Balance (in Shares) at Dec. 31, 2019 [1] 5,540,254 7,780,937 5,460,043 10,468,517 4,144,887     9,046,274      
Issuance of redeemable convertible preferred shares $ 1,177 1,177  
Issuance of redeemable convertible preferred shares (in Shares)       394,626              
Exercise and conversion of warrants $ 290 290  
Exercise and conversion of warrants (in Shares)           71,977          
Share-based compensation 439   439
Warrants to service providers 52   52
Exercise of options [2] 30   30
Exercise of options (in Shares)               226,154      
Net loss   (15,625) (15,625)
Balance at Dec. 31, 2020 $ 650 [1] $ 9,394 [1] $ 2,500 [1] $ 32,159 [1] $ 10,447 [1] $ 290 [1] 55,440 [1] [1],[2] 1,397 [1] (61,554) [1] (60,157)
Balance (in Shares) at Dec. 31, 2020 [1] 5,540,254 7,780,937 5,460,043 10,863,143 4,144,887 71,977   9,272,428      
Exercise of warrants $ 8,027 8,027  
Exercise of warrants (in Shares)           1,194,886          
Conversion of preferred shares into ordinary shares $ (650) $ (9,394) $ (2,500) $ (32,159) $ (10,447) $ (8,317) (63,467) [2] 63,467 63,467
Conversion of preferred shares into ordinary shares (in Shares) (5,540,254) (7,780,937) (5,460,043) (10,863,143) (4,144,887) (1,266,863)   35,056,127      
Conversion of convertible loan to ordinary shares [2]   30,844 30,844
Conversion of convertible loan to ordinary shares (in Shares)               3,205,020      
Issuance of ordinary shares, net of issuance costs [2] 91,990 91,990
Issuance of ordinary shares, net of issuance costs (in Shares)               13,866,887      
Exercise of warrants [2] 9,222 9,222
Exercise of warrants (in Shares)               872,614      
Share-based compensation   2,211 2,211
Warrants to service providers 115 115
Exercise of options [2]   223 223
Exercise of options (in Shares)               743,780      
Net loss (58,092) (58,092)
Balance at Dec. 31, 2021 [1] [1] [1] [1] [1] $ 199,469 $ (119,646) $ 79,823
Balance (in Shares) at Dec. 31, 2021     [1] [1],[2] [1]     63,016,856      
[1] Prior period share information has been retroactively adjusted to reflect the 1:46.25783 stock split and the changes in par value from NIS 0.01 NIS to 0.000216 effected on October 7, 2021. See also Note 12, Share Capital, for details.
[2] Represents less than $1.